Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
暂无分享,去创建一个
H. Farkas | M. Magerl | S. Kivity | B. Giannetti | A. Kessel | A. Reshef | A. Relan | M. Klimaszewska-Rembiasz | S. Fritz | D. Moldovan | V. Grivcheva-Panovska | V. Gutová
[1] H. Longhurst. Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus , 2018, Front. Med..
[2] R. Lockey,et al. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update , 2018, Allergy.
[3] M. Hutmacher,et al. Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema , 2018, CPT: pharmacometrics & systems pharmacology.
[4] H. Farkas. Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients , 2018, Pediatric Drugs.
[5] W. Aberer,et al. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. , 2017, The journal of allergy and clinical immunology. In practice.
[6] William H. Yang,et al. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial , 2017, The Lancet.
[7] H. Farkas,et al. The relationship between anxiety and quality of life in children with hereditary angioedema , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[8] M. Riedl,et al. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. , 2017, The journal of allergy and clinical immunology. In practice.
[9] H. Farkas,et al. Health‐related quality of life among children with hereditary angioedema , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[10] M. Triggiani,et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency , 2016, Allergy.
[11] B. Zuraw,et al. Pediatric Hereditary Angioedema , 2016, Clinical pediatrics.
[12] J. Skopál,et al. Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency , 2015, Orphanet Journal of Rare Diseases.
[13] T. Craig,et al. Plasma‐derived C1‐INH for managing hereditary angioedema in pediatric patients: A systematic review , 2015, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[14] J. Bernstein,et al. Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency. , 2015, Immunotherapy.
[15] J. Bernstein,et al. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. , 2015, The journal of allergy and clinical immunology. In practice.
[16] J. Bernstein,et al. Clinical features of pediatric hereditary angioedema. , 2014, The journal of allergy and clinical immunology. In practice.
[17] J. Bernstein,et al. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[18] A. Gompel,et al. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[19] M. Maurer,et al. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe , 2013, Allergy, Asthma & Clinical Immunology.
[20] R. Tachdjian,et al. Use of Ecallantide in Pediatric Hereditary Angioedema , 2013, Pediatrics.
[21] J. Sheikh,et al. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. , 2013, The Journal of allergy and clinical immunology.
[22] R. Lockey,et al. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[23] K. Bork,et al. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. , 2012, The Journal of allergy and clinical immunology.
[24] M. Triggiani,et al. Efficacy and safety of recombinant human C1‐inhibitor for the treatment of attacks of hereditary angioedema: European open‐label extension study , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[25] J. Nuijens,et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.
[26] H. Farkas. Pediatric hereditary angioedema due to C1-inhibitor deficiency. , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[27] B. Zuraw. Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.
[28] K. Bork,et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.
[29] M. López-Trascasa,et al. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[30] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.
[31] P. Harris,et al. Koilonychia in Ladakhis , 1988, The British journal of dermatology.
[32] M. Kerr,et al. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency. , 1985, Immunology.